Regulation of Vitamin D Metabolism by Washed Microbiota Transplantation in Patients With IBD
NCT04989374 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-11-08
Summary
WMT could effectively induce clinical response and maintain remission in patients with Inflammatory bowel disease (IBD). VD maintains gut microbiota and gut microbiota alter intestinal vitamin D metabolism (VDM),The aim of this study was to evaluate the effect of WMT on VD metabolism by measuring the level of serum 25(OH)D in IBD patients before and after treatment
Conditions
Sponsors & Collaborators
-
The Second Hospital of Nanjing Medical University
lead OTHER
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-01
- Primary Completion
- 2021-12-30
- Completion
- 2021-12-30
Countries
- China
Study Locations
More Related Trials
-
Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease
NCT04879914 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota in IBD With Comorbid Depressive Disorder
NCT07252427 ·Status: RECRUITING
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome.
NCT04890405 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Transplantation for Irritable Bowel Syndrome
NCT03613545 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Mediterranean Diet and the Gut Microbiome
NCT03269032 ·Status: COMPLETED ·Phase: NA
-
Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase
NCT02566629 ·Status: UNKNOWN
-
Effects of Pectin on Flora Intestinal Colonization and Maintenance After Fecal Transplantation
NCT02016469 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT05740319 ·Status: RECRUITING ·Phase: NA
-
Effect of Mediterranean Diet in Inflammatory Bowel Disease
NCT05973500 ·Status: RECRUITING ·Phase: NA
-
Neural Circuit Mechanism of Inflammatory Bowel Disease Combined With Depression
NCT06471894 ·Status: NOT_YET_RECRUITING
-
Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota
NCT02040922 ·Status: UNKNOWN
-
Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
NCT02651740 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients
NCT05900752 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Fecal Microbiota Transplantation
NCT04706611 ·Status: RECRUITING ·Phase: NA
-
Donor Selection for Faecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT06171126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of Probiotics in Patients With IBD
NCT05652621 ·Status: RECRUITING ·Phase: NA
-
Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre
NCT05058131 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT06960369 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS
NCT03306381 ·Status: COMPLETED ·Phase: NA
-
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D
NCT06543498 ·Status: COMPLETED ·Phase: NA
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome
NCT02249169 ·Status: COMPLETED